Sign in

Antidote for Aging: Synthetic Viper Venom Smooths Over a Cross-cultural Concern

Contact Author Remo Campiche, Marc Heidl, Rainer Voegeli and Dominik Imfeld, DSM Nutritional Products, Kaiseraugst, Switzerland; Pierre Séroul, Newtone Technologies, Lyon, France; and Anthony V. Rawlings, AVR Consulting Ltd., Northwich, England
Fill out my online form.

The perception and manifestation of aging and beauty vary depending on ethnicity and region.1 Recent studies of women having various skin types showed significant differences in the appearance of pores,2 wrinkles and sagging,3–5 as well as transepidermal water loss,6 skin capacitance6, 7 and biochemical markers.8 Furthermore, differences in skin architecture, structure and composition depending on ethnicity can lead to different onsets of aging,9 although UV irradiation is still the most important factor. More recently, the term skin aging exposome was also penned10 to include other environmental factors such as air pollution, smoking or lifestyle.

Concerning visual signs of skin aging, wrinkles are the most important to consumers.11 Facial wrinkles can be grouped together, e.g., as forehead wrinkles, crow’s feet near the eyes, mouth frown lines, the nasolabial folds and vertical lines on the upper and lower lips. In relation, a few studies have been conducted to determine the efficacy of treatments on these disparate facial sites.12, 13

One of the main molecular signs of skin aging is the decrease and disorganization of functional collagen in the dermis.14 This results from either increased collagen degradation, due to chronological aging or photoaging, or from decreased de novo synthesis. Means to protect collagen degradation or to enhance collagen synthesis and maturation would hence be beneficial to counteract skin aging and wrinkle formation. In relation, lysyl hydroxylases (LHs), particularly LH3, encoded by the gene PLOD3,15 and lysyl oxidases (LOXs), particularly LOXL2,16 have been found to be instrumental in the proper maturation of collagen fibers.

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

Dipeptide diaminobutyroyl benzylamide diacetate, hereafter referred to as DABBAa, is a cosmetic ingredient modeled after a toxic protein found in venom of the temple viper, Tropidolaemus wagleri. The protein, Waglerin-1, acts by inhibiting the nicotinic acetylcholine receptor,17 which blocks muscular contraction. DABBA acts on the same receptor, blocking the muscle nicotinic acetylcholine receptor but in a transient and reversible manner.17 This leads to a relaxation of the mimic muscles in the face, smoothing out facial wrinkles—similar to botulinum toxin but without being injected subcutaneously. In addition, facial expression is not lost.

The present article explores the effects of DABBA by investigating facial wrinkles in three different skin types: Asian, black African and Caucasian. Results indicate both skin type- and facial site-dependent manifestations of the signs of aging. The active also was shown to positively affect the collagen maturation pathway.

Materials and Methods

As stated, DABBA was modeled after a basic amino acid-proline-basic amino acid repeat that is responsible for the activity of Waglerin-1. The repeat consists specifically of arginine-proline-lysine. By distinct side-chain modifications, the peptide Beta-Ala-Pro-Dab-NH-Bzl * 2AcOH was developed for anti-wrinkle activities and tested as described next.

In vitro muscle contraction: Human muscle cells were cultured in gelatin-coated plates until they formed myo-fibers without contraction. To induce contraction, they were co-cultured with spinal cord explants containing dorsal root ganglions from rat embryos. After one day, neurites were growing from the explants. Upon contact with the myotubes, they induced first contractions. After 21 days, the culture displayed high levels of mature neuromuscular junctions with cross-striated, innervated muscle fibers.

At this point, 0.5 mM of DABBA was administered and the cessation of muscle contractions was monitored using an inverted microscope equipped for video recordingb. The results were expressed as the number of fiber contractions in 30 sec, and as a percentage of the contraction frequency compared with the contraction frequency before incubation.

In vitro gene expression in human dermal fibroblasts: Normal human dermal fibroblasts from the abdominal skin of female donors, 18 and 63 years old, were exposed to DABBA for 24 hr. Gene expression averages were measuredc for Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 3 (PLOD3); Lysyl Oxidase Like 2 (LOXL2) was assessed from technical duplicates.

Study 1 in vivo, Caucasian skin: For this full-face, placebo controlled, 28-day study, test creams (see Formula 1) were applied twice daily to the faces of 15 female Caucasians (41–60 years old, 52.5 ± 2). The evolution of wrinkles in their crow’s feet area and foreheads were evaluatedd at baseline and after the four weeks of treatment.

Study 2 in vivo, Caucasian, Asian and black African skin: In a second full-face, placebo controlled, 28-day study, 150 female volunteers having one of three different skin phototypes were enrolled. The test creams (see Formula 1) were applied twice daily. Fifty subjects participated per group, wherein 25 applied a placebo and 25 applied the active test cream.

Caucasians were recruited from Lyon, France (46.2 ± 3.6 years old, Fitzpatrick skin phototypes II–III); Asians were recruited from Bangkok, Thailand (47.3 ± 3.5 years old, Fitzpatrick skin phototypes III–IV); and black Africans were recruited from Quatre Bornes, Island of Mauritius (56.5 ± 4.5 years old, Fitzpatrick skin phototypes V–VI). Cross-polarized images were taken of each subject’s half-face, at a 45-degree angle, and front face, at a zero-degree angle.

Caucasian and black African subjects were photographed using one systeme and Asian subjects, with anotherf. Wrinkle lengths and surfaces were analyzed from the images. To compare the data, measurements were normalized and calculated in mm and mm2.

DABBA blocks muscular contraction, leading to transient muscle relaxation that smooths facial wrinkles.

In vitro Results: Muscle Contraction

In the co-culture assay using human muscle cells and rat spinal cord explants, 0.5 mM of DABBA significantly inhibited muscle contraction by 82% (p < 0.05) in a time-dependent manner 2 hr after application (see Figure 1a). This inhibition persisted for two days and contraction was fully restored after four days, indicating the peptide is fast-acting, long-lasting and fully reversible. These results suggest DABBA correctly mimics Waglerin-1, inhibiting the nicotinic acetylcholine receptor and leading to the relaxation of facial expression lines (see Figure 1b).

To explain DABBA’s anti-wrinkle mechanism of action, consider under normal conditions, acetylcholine (ACh) is released from neurons and binds to the muscle nicotinic acetylcholine receptor (mnAChR). This leads to depolarization and muscle contraction (see left scheme, Figure 1b). On the right scheme (also Figure 1b), DABBA is believed to block mnAChR, making it inaccessible to ACh and in turn, preventing depolarization. Thus, the muscle stays relaxed. It is noteworthy that botulinum toxin acts on the inhibition of ACh release, blocking signaling transfer from neuron to muscle.21 This pre-synaptic activity is slightly different from DABBA, which is acts post-synaptically but exhibits a similar effect.

In vitro Results: Gene Expression

To assess the effects of DABBA on additional anti-aging pathways, human dermal fibroblasts were incubated with the active as described previously. DABBA increased the expression of PLOD3 by 4.5-fold and LOXL2 by 2.4-fold (see Figure 2a). Interesting, for PLOD3, up-regulation was observed only in the 63-year-old fibroblasts, indicating its effects are age-dependent. This may suggest specific activity, where reconstitution of the extracellular matrix is most needed.

To explain DABBA’s effects on the genetic expression of pro-collagen markers, note that both PLOD3 and LOXL2 are involved in the maturation of collagen fibers (see Figure 2b).16, 18 PLOD3 encodes the protein LH3, which adds hydroxyl groups to lysine residues of the pro-collagen molecule. This is essential for pro-collagen to form a triple helix, which is then further processed by LOXL2, among others, to generate mature collagen fibers.22

In vivo Results: Caucasian Skin

As noted, Caucasian female subjects were recruited to assess the activity of DABBA on forehead wrinkles (see Figure 3) and the crow’s feet area (data not shown). Parameters for wrinkle depth, Ra, wrinkle amplitude, Rz, and skin roughness, Rt, all decreased significantly by 15–21% (p < 0.05 for Rt, p < 0.01 for both Ra and Rz) with a formulation containing 4% DABBA; this was not the case for the placebo group.

In vivo Results: Different Ethnicities

In general, it is assumed Caucasian skin shows an earlier onset of the signs of aging than Asian or black African skin.19 This may be due to the decrease in photoaging generally attributed to darker skin phototypes. Recently, this concept was challenged with the finding that aging also depends on the facial site studied.20 This suggests facial aging is a complex phenomenon, dependent not only on skin type, but also on the facial area.

Another study recently found skin hydration shows dramatic variation depending on skin phototype or facial site, with large gradients on relatively small areas.6 These observations inspired us to examine differences in treatment effects of the anti-aging peptide in volunteers having different skin phototypes.

As noted, women from three regions having different skin types applied either a 4% DABBA-containing formula or placebo formula for 28 days. The results in Figure 4a show that the treatment effects were as diverse as the reported appearance of facial wrinkles themselves.

The decrease in forehead wrinkle depth found initially in the Caucasian skin-only study was confirmed (-8.6%, p < 0.05) (see Figure 3) but for the other facial sites, the treatment effects were more complex. For Caucasian skin, a decrease in mouth frown lines and vertical lines on the upper lip was observed, up to 23% in length. Asian subjects showed a decrease in mouth frown lines of 4% in depth, and vertical lines on the upper lip up to 8% for length and depth. Black African skin showed a decrease in the depth of vertical lines on the upper lip by 2%.

A complex pattern of wrinkle appearance was revealed, suggesting facial aging may be more complicated than previously thought.

In addition, the volunteers completed a self-assessment questionnaire (see Figure 4b). Overall, according to the test subjects, the DABBA-containing formula outperformed the placebo formula. Volunteers reported having fewer forehead wrinkles, thus confirming measurements (see Figure 3 and Figure 4a). Furthermore, they felt they had smoother and finer skin, and their facial features seemed lifted.


From the described studies, some conclusions can be made. First, besides its muscle-relaxing activity, DABBA induces the expression of PLOD3 and LOXL2, two genes coding for proteins involved in collagen fiber maturation. This suggests added anti-aging benefits.

Also, in two in vivo studies, one of Caucasian subjects, and the other of subjects having three differently pigmented skin types, significant effects were observed. A robust decrease in the depth of forehead wrinkles and crow’s feet was shown in Caucasian skin. Also, distinct effects on mouth frown lines and vertical lines of the upper lip were observed in three, i.e., Caucasian, Asian and black African, skin types.

Finally, a complex pattern of wrinkle appearance was revealed in volunteers of all three subject groups. Taken together, this data adds to the knowledge that facial aging may be a more complex phenomenon than previously thought. The present findings also allow product developers to develop specific anti-aging compounds dependent on skin phototype or facial site.

Acknowledgements: This study was funded by DSM Nutritional Products.


  1. CE Lockenhoff et al, Perceptions of aging across 26 cultures and their culture-level associates, Psychol Aging 24(4) 941-54 (2009)
  2. F Flament et al, Facial skin pores: A multiethnic study, Clin Cosmet Invest Dermatol 8 85-93 (2015)
  3. K Tsukahara et al, Comparison of age-related changes in facial wrinkles and sagging in the skin of Japanese, Chinese and Thai women, J Dermatol Sci 47(1) 19-28 (2007)
  4. S Nouveau-Richard et al, Skin aging: A comparison between Chinese and European populations. A pilot study, J Dermatol Sci 40(3) 187-93 (2005)
  5. T Fujimura, et al, Roughness analysis of the skin as a secondary evaluation criterion in addition to visual scoring is sufficient to evaluate ethnic differences in wrinkles. Int J Cosmet Sci 31(5) 361-7 (2009)
  6. R Voegeli et al, A novel continuous colour mapping approach for visualization of facial skin hydration and transepidermal water loss for four ethnic groups, Int J Cosmet Sci 37(6) 595-605 (2015)
  7. R Voegeli, AV Rawlings and B Summers, Facial skin pigmentation is not related to stratum corneum cohesion, basal transepidermal water loss, barrier integrity and barrier repair, Int J Cosmet Sci 37(2) 241-52 (2015)
  8. N Raj et al, Variation in the activities of late stage filaggrin processing enzymes, calpain-1 and bleomycin hydrolase, together with pyrrolidone carboxylic acid levels, corneocyte phenotypes and plasmin activities in non-sun exposed and sun-exposed facial stratum corneum of different ethnicities, Int J Cosmet Sci (2016)
  9. Y Sugiyama-Nakagiri et al, Ethnic differences in the structural properties of facial skin, J Dermatol Sci 53(2) 135-9 (2009)
  10. J Krutmann et al, The skin aging exposome, J Dermatol Sci (2016)
  11. A Nkengne and C. Bertin, Aging and facial changes-documenting clinical signs, part 1: Clinical changes of the aging face, SKINmed 11 281-286 (2013)
  12. J Hatzis, The wrinkle and its measurement—a skin surface profilometric method, Micron 35(3) 201-19 (2004)
  13. GE Piérard, I Uhoda and C. Piérard-Franchimont, Update on the histological presentation of facial wrinkles, Eur J Dermatol 12(6) 13-14 (2002)
  14. T Quan and GJ Fisher, Role of age-associated alterations of the dermal extracellular matrix microenvironment in human skin aging: A mini-review, Gerontology 61(5) 427-34 (2015)
  15. M Risteli et al, Reduction of lysyl hydroxylase 3 causes deleterious changes in the deposition and organization of extracellular matrix, J Biol Chem 284(41) 28204-11 (2009)
  16. YM Kim, EC Kim and Y Kim, The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin, Mol Biol Rep 38(1) 145-9 (2011)
  17. JJ McArdle et al, Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor, J Pharmacol Exp Ther 289(1) 543-50 (1999)
  18. R Myllyla et al, Expanding the lysyl hydroxylase toolbox: New insights into the localization and activities of lysyl hydroxylase 3 (LH3), J Cell Physiol 212(2) 323-9 (2007)
  19. GG Hillebrand, MJ Levine and K Miyamoto, The age-dependent changes in skin condition in African Americans, Asian Indians, Caucasians, East Asians and Latinos, IFSCC Magazine 4(4) 259-266 (2001)
  20. A Vierkotter et al, Extrinsic skin aging in German, Chinese and Japanese women manifests differently in all three groups depending on ethnic background, age and anatomical site, J Dermatol Sci (2016)
  21. R Small, Botulinum toxin injection for facial wrinkles, Am Fam Physician 90(3) 168-75 (2014)
  22. DM Gilkes, GL Semenza and D Wirtz, Hypoxia and the extracellular matrix: Drivers of tumor metastasis, Nat Rev Cancer 14(6) 430-9 (2014)

Related Content



Figure 1. Inhibition of muscle cell contraction by DABBA

Figure 1. Inhibition of muscle cell contraction by DABBA

in vitro (a) and its proposed botulinum toxin-like mode of action (b)

Figure 2. Gene-expression of PLOD3 and LOXL2 in human dermal fibroblasts after treatment

Figure 2. Gene-expression of PLOD3 and LOXL2 in human dermal fibroblasts after treatment

with DABBA or TGF-β1 (positive control); expression levels are relative to house-keeping genes (GAPDH and RPS28) at 100% (a); proposed mode of action for DABBA’s anti-aging activity (b)

Figure 3. Measurement of forehead wrinkles on volunteers

Figure 3. Measurement of forehead wrinkles on volunteers

using 4% DABBA, compared with the placebo formula (above); the test formula shows decreased wrinkle depth after 28 days of treatment with DABBA (bottom; green profile) compared with the beginning of the study (red profile)

Figure 4. Efficacy of DABBA on facial wrinkles

Figure 4. Efficacy of DABBA on facial wrinkles

Caucasian skin depth of forehead wrinkles decreased significantly over baseline (*p < 0.05 by ANOVA followed by Tukey test) (a); and self-assessment questionnaire after four weeks of treatment (b)

Footnotes [CT1709 Campiche]

a SYN-AKE or SYN-STAR (INCI: Dipeptide Diaminobutyroyl Benzylamide Diacetate (and) Glycerin (and) Water (Aqua)), DSM

b Diaphot 300 inverted microscope with DMX 1200 camera, Nikon Corp.

c LightCycler System, Roche Molecular Diagnostics

d Primos 3D, Canfield

e ColorFace System, Newtone Technologies

f Visia CR System, Canfield

Formula 1. Test Creams

Formula 1. Test Creams

For this full-face, placebo controlled, 28-day study, test creams were applied twice daily to the faces of 15 female Caucasians (41–60 years old, 52.5 ± 2). The evolution of wrinkles in their crow’s feet area and foreheads were evaluated at baseline and after the four weeks of treatment.

Next image >